Astrana Health, Inc. (ASTH)

NasdaqCM Currently down 8.94 (-18.58%) in today's trading session

1 member of Congress has disclosed 6 trades in Astrana Health, Inc. (ASTH) via STOCK Act filings. The most recent disclosure was a sale by Judy Chu on 19 August 2025. Aggregate disclosed activity totals roughly $525K in purchases and $525K in sales (midpoint estimates from bracketed disclosure amounts).

Astrana Health, Inc. is currently trading at $39.18, positioned at 63% of its 52-week range ($18.08 – $51.60).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$39.18
24h Change
-8.94 (-18.58%)
52 Week Range
$18.08$51.60
View on NASDAQ

Astrana Health, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for ASTH

Select to highlight on chart
2 transactions
Compliance: 33%
Judy Chu19 Aug 202530 Aug 2025SaleStock$100,001 - $250,000N/A
Judy Chu19 Aug 202530 Aug 2025PurchaseStock$100,001 - $250,000+30.91%

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.94B

Volume

55.68K

Beta

0.90

P/E Ratio

47.21

Fundamentals

EPS

$0.83

Div. Yield

Open

$39.18

Day Range

$38.64 — $39.85

Company Information

Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NASDAQ · USD
Country
US
CEO
Brandon K. Sim
IPO Date
2009-03-11

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating...

Earnings

Next Report

Q3 2026

5 Nov

EPS Est.

$0.40

Rev. Est.

$1B

Days Until

73

Recent Quarters

Q2 20266 Aug
EPS$0.40
Beat 19.1%
Q1 20267 May
EPS$0.30
Beat 3.5%
Q4 20252 Mar
EPS$0.12
Miss 20.0%
Q3 20256 Nov
EPS$0.01
Miss 97.9%
Q2 20257 Aug
EPS$0.19
Miss 47.2%
Q1 20258 May
EPS$0.14
Miss 39.1%
Q4 202427 Feb
EPS$-0.15
Miss 168.2%
Q3 20247 Nov
EPS$0.33
Beat 3.1%
Q2 20247 Aug
EPS$0.40
Beat 2.6%
Q1 20247 May
EPS$0.31
Beat 3.3%
Q4 202327 Feb
EPS$0.26
Beat 73.3%
Q3 20237 Nov
EPS$0.47
Beat 74.1%
Q2 20237 Aug
EPS$0.28
Beat 12.4%
Q1 20238 May
EPS$0.31
Beat 1.1%
Q4 202223 Feb
EPS$-0.06
Beat 14.3%
Q3 20223 Nov
EPS$0.56
Beat 75.8%
Q2 20224 Aug
EPS$0.25
Beat 23.1%
Q1 20225 May
EPS$0.31
Miss 3.1%

No dividend data available for this stock.

Stock Splits

Split History

27 Apr 2015Reverse Split
Ratio1:10
26 Nov 2007Reverse Split
Ratio1:136

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ASTH

Which members of Congress have traded ASTH?
1 member of Congress has disclosed 6 trade in Astrana Health, Inc. (ASTH) under the STOCK Act: Judy Chu.
When was ASTH most recently disclosed by Congress?
The most recent ASTH disclosure was a sale by Judy Chu on 19 August 2025.
What is the total disclosed congressional trading volume for ASTH?
Members of Congress have disclosed approximately $525K in ASTH purchases and $525K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in ASTH?
This ASTH page updates as soon as new STOCK Act disclosures are filed for Astrana Health, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.